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Letter to the Editor 
 
Medical devices for cystic fibrosis care may be portable reservoirs of potential 
pathogens 
 
Sir, 
 
As recently reported, there is increasing association between the opportunistic 
pathogen Stenotrophomonas maltophilia and pulmonary exacerbations in cystic 
fibrosis (CF) 1.  There has been further literature regarding approaches for 
surveillance of S. maltophilia in this patient population, potential prediction of clinical 
outcomes based on such monitoring and, in light of escalating incidence of multidrug 
resistance 2, the potential benefit of subsequent early and appropriate  antimicrobial 
treatment 3 4.    
 
In response to an observation made by a nine-year old CF patient at his routine clinic 
visit that the plastic tubing of his Positive Expiratory Pressure (PEP) therapy device 
(TheraPEP®) had become discoloured, microbiological analysis of swabs confirmed 
presence of S. maltophilia.   While cognisant that S. maltophilia has been identified 
in hospital-use devices such as ventilators, humidifiers and nebulizers used to 
deliver aerosolized therapy to inpatients with cystic fibrosis 5, as well as hospital tap 
water and water used for bronchoscope flushing 6, we are not aware of any previous 
reports of its isolation from portable home- and hospital-use devices. A detailed 
review of available guidelines for nebuliser care by O’Malley reported that, against 
Cystic Fibrosis Foundation guidelines, manufacturers sometimes advised use of tap 
water as a final step in rinsing respiratory equipment, when sterile water should be 
used 7. This instance of contamination may have occurred due to that practice.  
 
PEP devices are ubiquitous in hospital CF care. Therefore, although there have 
been reports of successful elimination of biofilm and microbial contamination 
reservoirs in other hospital sites such as washbasin U-bends 8, vigilance regarding 
portable pulmonary devices may help in preventing outbreaks such as that caused 
by S. maltophilia forming a biofilm in the flexible plastic tube attached to a carbon 
filter for potable water in an ICU kitchen 9. 
 
The detection of a potential CF pathogen in a patient’s TheraPEP® device raises the 
possibility that physiotherapy airway clearance adjuncts may themselves represent a 
source of airway infection.  
 
Competing interests None declared. 
 
Funding sources None. 
 
Patient consent Obtained. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
REFERENCES 
 
1. Looney WJ, Narita M, Mühlemann K. Stenotrophomonas maltophilia: an emerging 
opportunist human pathogen. Lancet Infect Dis 2009;9(5):312-23. 
 
2. Rutter WC, Burgess DR, Burgess DS. Increasing incidence of multidrug 
resistance among cystic fibrosis respiratory bacterial isolates. Microb Drug Resist 
2017;23(1):51-5.  
  
3. Wettlaufer J, Klingel M, Yau Y, et al. Longitudinal study of Stenotrophomonas 
maltophilia antibody levels and outcomes in cystic fibrosis patients. J Cyst Fibros 
2017;16(1):58-63 
 
4. Amin R, Waters V. Antibiotic treatment for Stenotrophomonas maltophilia in 
people with cystic fibrosis. Cochrane Database Syst Rev 2016;14(7):CD009249. doi: 
10.1002/14651858.CD009249.pub4. 
 
5. Denton M, Rajgopal A, Mooney L, et al. Stenotrophomonas maltophilia 
contamination of nebulizers used to deliver aerosolized therapy to inpatients with 
cystic fibrosis. J Hosp Infect 2003;55(3):180-3. 
 
6. Vincenti S, Quaranta G, De Meo C, et al. Non-fermentative gram-negative 
bacteria in hospital tap water and water used for haemodialysis and bronchoscope 
flushing: prevalence and distribution of antibiotic resistant strains. Sci Total Environ 
2014;5(499):47-54. 
 
7. O'Malley CA. Device cleaning and infection control in aerosol therapy. Respir Care 
2015;60(6):917-27. 
 
8. Swan JS, Deasy EC, Boyle MA, et al. Elimination of biofilm and microbial 
contamination reservoirs in hospital washbasin U-bends by automated cleaning and 
disinfection with electrochemically activated solutions. J Hosp Infect 2016;94(2):169-
74. 
 
9. Guyot A, Turton JF, Garner D. Outbreak of Stenotrophomonas maltophilia on an 
intensive care unit. J Hosp Infect 2013;85(4):303-7.  
 
Barry Linnane a, b  
Louise Collins a 
Neidin Bussmann a 
Nuala H O’Connell a, b 
Colum P Dunne b*    
 
a
 University Hospital Hospital, Dooradoyle, Limerick, Ireland 
b
 Graduate Entry Medical School and Centre for Interventions in Infection, 
Inflammation & Immunity (4i),  University of Limerick, Limerick, Ireland 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
* Corresponding author  
